We have spent a lot of time over the past few months helping you learn about Shared Medical Appointments and Patient Centered Medical Homes, and most of the time we all think about seniors as the most likely candidates. This week, our current Doctor of Pharmacy candidate, Daniel Schultz, spoke with Adam Lee at the American Academy of Family Physicians about a recent survey showing that a majority of 18-30 year olds wanted a medical home for their health care. Click here to read what the AAFP survey found out.
Just a couple of weeks ago Germany and France decided to remove Actos from their respective approved drugs list because of associated complications. If this occurs in the US then that would appear to finish off the class. But there is news of a new TZD, Balaglitazone, which is heading towards the market. Can any of you imagine the FDA approving a new TZD? Dr. Reddy’s Laboratories says this one is different. Check out this week’s Item #4, Experimental TZD Balaglitazone Shows Fewer Side Effects, to learn more.
Look for our upcoming GLP-1 series Issue #3 where we will share some of the results of our recent survey. A big thank you to all of you who gave us your feedback and insight on GLP-1 therapy!
Topics: A visit with Insulindependence, a group that encourages teens and young adults with type 1 to reach new heights. Also, a savory soup from the dLife kitchen, and another extreme diabetes makeover. Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on dLife.com.
Relax and rock out! Close Concerns/diaTribe & TCOYD invite you to join us for some spectacular learning and camaraderie on your last night in San Diego this June. Enjoy cocktails & no-holds-barred discussions with lots of audience Q&A, all benefiting Taking Control Of Your Diabetes.
Please answer this week’s poll: For type 2 patients on insulin, would you recommend a GLP-1 medication to help with weight loss and glucose control?
Check out this week’s “Test Your Diabetes Knowledge” question!
Dave Joffe, Editor-in-chief